search
long COVID
Trends
- 1Study suggests COVID may worsen existing health problems long-termโ"COVID may worsen existing health problems long-term, study suggests" In other breaking news: Fork Found in Kitchen http
A new study suggests that a COVID-19 infection may worsen pre-existing health problems over the long term, adding to the growing body of research on the virus's lasting effects. The finding is being shared with a tone of exasperation by some commentators, who note it confirms what public health advocates have long warned, and argue that the pandemic's ongoing impact is still being underestimated.
- 2COVID may worsen existing health conditions long-term, study findsโผCOVID may worsen existing health problems long-term, study suggests
A new study suggests that COVID-19 may worsen pre-existing health problems over the long term, adding to concerns about the lasting effects of infection. The finding points to a broader long-term health burden beyond long COVID itself, with implications for patients managing chronic conditions and for health systems assessing ongoing care needs.
- 3Healthcare workers hit hard by long COVID, study findsโHealthcare workers battle persistent long COVID: study
A new study indicates healthcare workers are battling persistent long COVID symptoms, with many continuing to experience fatigue, brain fog and other lasting effects well after infection. The findings highlight the ongoing toll of the pandemic on medical staff, raising concerns about workforce shortages and the need for better support and treatment for affected clinicians.
- 4Study examines post-COVID risks in asthma and COPD patientsโผRisk factors of post-COVID-19 symptoms, a cross-sectional study in patients with asthma and chronic obstructive lung disease
A new cross-sectional study published in Nature examines the risk factors associated with post-COVID-19 symptoms in patients with asthma and chronic obstructive pulmonary disease. The research aims to identify which characteristics make people with these chronic lung conditions more likely to experience lingering symptoms after infection, a question of ongoing concern for respiratory clinicians.
- 5
A US Senate committee has voted to hold Anthony Fauci, the former top US infectious disease official, in contempt of Congress. The vote escalates a long-running standoff between Republican lawmakers and Fauci over documents and testimony connected to the federal response to Covid-19 and the origins of the pandemic. Fauci, who led the National Institute of Allergy and Infectious Diseases for decades before retiring in 2022, remains a frequent target of congressional scrutiny, and the move is likely to deepen partisan fights over pandemic-era decisions.
- 6Nearly nine in ten post-covid patients never fully recoverโBijna negen op de tien mensen met post-covid herstelt niet volledig van zijn klachten. Ze moeten daar mee leren leven. D
A study by researchers at Frisius MC and the UMCG in Groningen finds that almost nine out of ten people with post-covid do not fully recover from their symptoms and have to learn to live with them. The researchers say the outcomes are disappointing, noting that the long-term impact of the condition has been clear for a long time. The findings are drawing attention in Dutch-language discussions about long covid care.
- 7Ontario starts Covid and flu vaccines for priority groups September 28โIf you live in Ontario and fit into one of these categories, you can get your Covid and flu vaccines beginning on Septem
Ontario is rolling out Covid and flu vaccinations beginning September 28 for priority groups, including hospital patients and staff, people aged 65 and older, and residents and staff of long-term care homes, retirement homes and similar settings. The early access is aimed at protecting the most vulnerable before the wider respiratory illness season, with broader eligibility for the general public expected to follow later.
- 8NIH trial finds antiviral drug fails to improve Long COVID symptomsโAntiviral drug did not improve Long COVID symptoms
Researchers with the National Institutes of Health report that an antiviral drug did not improve symptoms in patients with Long COVID. The finding comes from a federally funded trial and adds to a string of disappointing results in the search for effective treatments for the lingering condition, which affects millions of people worldwide. Clinicians and patient advocates say the result underscores how little proven therapy exists for the illness.